119 research outputs found

    Magneto-Electric Nano-Particles for Non-Invasive Brain Stimulation

    Get PDF
    This paper for the first time discusses a computational study of using magneto-electric (ME) nanoparticles to artificially stimulate the neural activity deep in the brain. The new technology provides a unique way to couple electric signals in the neural network to the magnetic dipoles in the nanoparticles with the purpose to enable a non-invasive approach. Simulations of the effect of ME nanoparticles for non-invasively stimulating the brain of a patient with Parkinson’s Disease to bring the pulsed sequences of the electric field to the levels comparable to those of healthy people show that the optimized values for the concentration of the 20-nm nanoparticles (with the magneto-electric (ME) coefficient of 100 V cm21 Oe21 in the aqueous solution) is 36106 particles/cc, and the frequency of the externally applied 300-Oe magnetic field is 80 Hz

    Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers

    Get PDF
    Although highly active anti-retroviral therapy has resulted in remarkable decline in the morbidity and mortality in AIDS patients, inadequately low delivery of anti-retroviral drugs across the blood–brain barrier results in virus persistence. The capability of high-efficacy-targeted drug delivery and on-demand release remains a formidable task. Here we report an in vitro study to demonstrate the on-demand release of azidothymidine 5â€Č-triphosphate, an anti-human immunodeficiency virus drug, from 30 nm CoFe2O4@BaTiO3 magneto-electric nanoparticles by applying a low alternating current magnetic field. Magneto-electric nanoparticles as field-controlled drug carriers offer a unique capability of field-triggered release after crossing the blood–brain barrier. Owing to the intrinsic magnetoelectricity, these nanoparticles can couple external magnetic fields with the electric forces in drug–carrier bonds to enable remotely controlled delivery without exploiting heat. Functional and structural integrity of the drug after the release was confirmed in in vitro experiments with human immunodeficiency virus-infected cells and through atomic force microscopy, spectrophotometry, Fourier transform infrared and mass spectrometry studies

    Bandwidth-Effective DRAM Cache for GPUs with Storage-Class Memory

    Full text link
    We propose overcoming the memory capacity limitation of GPUs with high-capacity Storage-Class Memory (SCM) and DRAM cache. By significantly increasing the memory capacity with SCM, the GPU can capture a larger fraction of the memory footprint than HBM for workloads that oversubscribe memory, achieving high speedups. However, the DRAM cache needs to be carefully designed to address the latency and BW limitations of the SCM while minimizing cost overhead and considering GPU's characteristics. Because the massive number of GPU threads can thrash the DRAM cache, we first propose an SCM-aware DRAM cache bypass policy for GPUs that considers the multi-dimensional characteristics of memory accesses by GPUs with SCM to bypass DRAM for data with low performance utility. In addition, to reduce DRAM cache probes and increase effective DRAM BW with minimal cost, we propose a Configurable Tag Cache (CTC) that repurposes part of the L2 cache to cache DRAM cacheline tags. The L2 capacity used for the CTC can be adjusted by users for adaptability. Furthermore, to minimize DRAM cache probe traffic from CTC misses, our Aggregated Metadata-In-Last-column (AMIL) DRAM cache organization co-locates all DRAM cacheline tags in a single column within a row. The AMIL also retains the full ECC protection, unlike prior DRAM cache's Tag-And-Data (TAD) organization. Additionally, we propose SCM throttling to curtail power and exploiting SCM's SLC/MLC modes to adapt to workload's memory footprint. While our techniques can be used for different DRAM and SCM devices, we focus on a Heterogeneous Memory Stack (HMS) organization that stacks SCM dies on top of DRAM dies for high performance. Compared to HBM, HMS improves performance by up to 12.5x (2.9x overall) and reduces energy by up to 89.3% (48.1% overall). Compared to prior works, we reduce DRAM cache probe and SCM write traffic by 91-93% and 57-75%, respectively.Comment: Published in 2024 IEEE International Symposium on High-Performance Computer Architecture (HPCA'24

    Switching of Perpendicularly Polarized Nanomagnets with Spin Orbit Torque without an External Magnetic Field by Engineering a Tilted Anisotropy

    Full text link
    Spin orbit torque (SOT) provides an efficient way of generating spin current that promises to significantly reduce the current required for switching nanomagnets. However, an in-plane current generated SOT cannot deterministically switch a perpendicularly polarized magnet due to symmetry reasons. On the other hand, perpendicularly polarized magnets are preferred over in-plane magnets for high-density data storage applications due to their significantly larger thermal stability in ultra-scaled dimensions. Here we show that it is possible switch a perpendicularly polarized magnet by SOT without needing an external magnetic field. This is accomplished by engineering an anisotropy in the magnets such that the magnetic easy axis slightly tilts away from the film-normal. Such a tilted anisotropy breaks the symmetry of the problem and makes it possible to switch the magnet deterministically. Using a simple Ta/CoFeB/MgO/Ta heterostructure, we demonstrate reversible switching of the magnetization by reversing the polarity of the applied current. This demonstration presents a new approach for controlling nanomagnets with spin orbit torque

    Room-temperature Magnetic Ordering in Functionalized Graphene

    Get PDF
    Despite theoretical predictions, the question of room-temperature magnetic order in graphene must be conclusively resolved before graphene can fully achieve its potential as a spintronic medium. Through scanning tunneling microscopy (STM) and point I-V measurements, the current study reveals that unlike pristine samples, graphene nanostructures, when functionalized with aryl radicals, can sustain magnetic order. STM images show 1-D and 2-D periodic super-lattices originating from the functionalization of a single sub-lattice of the bipartite graphene structure. Field-dependent super-lattices in 3-nm wide “zigzag” nanoribbons indicate local moments with parallel and anti-parallel ordering along and across the edges, respectively. Anti-parallel ordering is observed in 2-D segments with sizes of over 20 nm. The field dependence of STM images and point I-V curves indicates a spin polarized local density of states (LDOS), an out-of-plane anisotropy field of less than 10 Oe, and an exchange coupling field of 100 Oe at room temperature

    Multifunctional TPP-PEG-biotin self-assembled nanoparticle drug delivery-based combination therapeutic approach for co-targeting of GRP78 and lysosome

    Get PDF
    Abstract Background In this study, a multifunctional tetraphenylporphyrin (TPP) conjugated polyethylene glycol with biotin (TPP-PEG-biotin) as a photo-dynamic therapy (PDT) material encapsulating a ruthenium complex 1 (Ru-1) was fabricated as self-assembled nanoparticle (Ru-1@TPP-PEG-biotin SAN) to co-target glucose-regulated protein 78 (GRP78) and the lysosome as a new anti-cancer therapeutic strategy. Results The MTT assay results reveals the enhanced anticancer activity of the Ru-1@TPP-PEG-biotin SANs due to the co-targeting of the GRP78 and lysosome. The Ru-1@TPP-PEG-biotin reduced level of GRP78 and lysosomal ceramide that contributed to the stability of the lysosomal membrane. The endoplasmic reticulum (ER) stress concomitant with the inhibition of GRP78 was clearly monitored by the phosphorylation of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), and inositol-requiring enzyme 1 α (IRE1α) kinases to indicate the activation of the unfolded protein response (UPR) signaling using immunofluorescence assay. On the other hand, the degradation of the lysosome was observed through PDT action by the Ru-1@TPP-PEG-biotin SAN treatment. This was confirmed by the co-localization assay showing the disappearance of cathepsin D and lysosomal-associated membrane protein 1 (LAMP1) in the lysosome. Conclusions Considering lysosome-mediated autophagy is an effective cancer cell survival mechanism, the degradation of the lysosome along with GRP78 inhibition by the Ru-1@TPP-PEG-biotin SAN combination therapy is suggested as a new co-targeting cancer treatment

    Interrupted aortic arch diagnosed with loss of femoral pulse in a patient undergoing patent ductus arteriosus ligation -A case report-

    Get PDF
    A 12-year-old boy with ventricular septal defect and patent ductus arteriosus was presented to the operating room. Upon clamping the patent ductus arteriosus, the femoral arterial pressure curve was lost; however, it returned upon unclamping. Upon further dissection, an interrupted aortic arch was found between the left subclavian artery and patent ductus arteriosus. The surgery was discontinued for further evaluation
    • 

    corecore